Wanderson Geraldo de Lima (Wanderson Geraldo Lima)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Nlrp Inflammasome

Top Venues

Drug and chemical toxicology

Clinical and experimental hypertension (New York, N.Y. : 1993)

This page only lists publications with an associated author ORCID identifier.

Publications

Aline Meireles Coelho, Isabela Ferreira Queiroz, Luiza Oliveira Perucci, Melina Oliveira de Souza, Wanderson Geraldo de Lima, Andre Talvani, Daniela Caldeira Costa
Piperine as Therapeutic Agent in Paracetamol-Induced Hepatotoxicity in Mice. Pharmaceutics 14 (9) (2022)
Aline Meireles Coelho, Isabela Ferreira Queiroz, Wanderson Geraldo de Lima, André Talvani, Luiza Oliveira Perucci, Melina Oliveira de Souza, Daniela Caldeira Costa
Temporal analysis of paracetamol-induced hepatotoxicity. Drug and chemical toxicology (2022)
Quênia Janaína Tomaz de Castro, Carolina Morais Araujo, Patrícia Yoshie Watai, Samara Stéfani de Castro E Silva, Wanderson Geraldo de Lima, Lenice Kappes Becker, Jamille Locatelli, Homero Nogueira Guimarães, Francisco F DE Lima Neto
Effects of physical exercise combined with captopril or losartan on left ventricular hypertrophy of hypertensive rats. Clinical and experimental hypertension (New York, N.Y. : 1993) 43 (6) (2021)
Tamara Cristina Moreira Lopes, Gregório Guilherme Almeida, Izabela Aparecida Souza, Diego Costa Borges, Wanderson Geraldo de Lima, Pedro Henrique Dias Moura Prazeres, Alexander Birbrair, Rosa Maria Esteves Arantes, David M Mosser, Ricardo Goncalves
High-Density-Immune-Complex Regulatory Macrophages Promote Recovery of Experimental Colitis in Mice. Inflammation 44 (3) (2021)
Débora Faria Silva, Levi Eduardo Soares Reis, Marina Guimarães Carvalho Machado, Douglas Daniel Dophine, Vinicius Roberto de Andrade, Wanderson Geraldo de Lima, Margareth Spangler Andrade, José Mário Carneiro Vilela, Alexandre Barbosa Reis, Gwenaelle Pound-Lana, Simone Aparecida Rezende, Vanessa Carla Furtado Mosqueira
Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis. Pharmaceutics 13 (7) (2021)